These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29082501)
1. Determination of Hepatotoxicity in iPSC-Derived Hepatocytes by Multiplexed High Content Assays. Sirenko O; Cromwell EF Methods Mol Biol; 2018; 1683():339-354. PubMed ID: 29082501 [TBL] [Abstract][Full Text] [Related]
2. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes. Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751 [TBL] [Abstract][Full Text] [Related]
3. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes. Ware BR; Berger DR; Khetani SR Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675 [TBL] [Abstract][Full Text] [Related]
4. Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing. Lu J; Einhorn S; Venkatarangan L; Miller M; Mann DA; Watkins PB; LeCluyse E Toxicol Sci; 2015 Sep; 147(1):39-54. PubMed ID: 26092927 [TBL] [Abstract][Full Text] [Related]
5. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496 [TBL] [Abstract][Full Text] [Related]
6. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening. Gómez-Lechón MJ; Tolosa L Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232 [TBL] [Abstract][Full Text] [Related]
7. High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells. Sirenko O; Hesley J; Rusyn I; Cromwell EF Assay Drug Dev Technol; 2014; 12(1):43-54. PubMed ID: 24229356 [TBL] [Abstract][Full Text] [Related]
8. A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis. Trask OJ; Moore A; LeCluyse EL Assay Drug Dev Technol; 2014; 12(1):16-27. PubMed ID: 24444127 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis. Sirenko O; Hancock MK; Hesley J; Hong D; Cohen A; Gentry J; Carlson CB; Mann DA Assay Drug Dev Technol; 2016 Sep; 14(7):381-94. PubMed ID: 27494736 [TBL] [Abstract][Full Text] [Related]
10. High-content screening technology for studying drug-induced hepatotoxicity in cell models. Tolosa L; Gómez-Lechón MJ; Donato MT Arch Toxicol; 2015 Jul; 89(7):1007-22. PubMed ID: 25787152 [TBL] [Abstract][Full Text] [Related]
11. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes. Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329 [TBL] [Abstract][Full Text] [Related]
12. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines. Gao X; Liu Y Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825 [TBL] [Abstract][Full Text] [Related]
13. A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®. Bircsak KM; DeBiasio R; Miedel M; Alsebahi A; Reddinger R; Saleh A; Shun T; Vernetti LA; Gough A Toxicology; 2021 Feb; 450():152667. PubMed ID: 33359578 [TBL] [Abstract][Full Text] [Related]
14. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2. Kang SJ; Lee HM; Park YI; Yi H; Lee H; So B; Song JY; Kang HG Cell Biol Toxicol; 2016 Oct; 32(5):403-17. PubMed ID: 27287938 [TBL] [Abstract][Full Text] [Related]
15. High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity. Peyre L; de Sousa G; Barcellini-Couget S; Luzy AP; Zucchini-Pascal N; Rahmani R Toxicol In Vitro; 2015 Oct; 29(7):1916-31. PubMed ID: 26239606 [TBL] [Abstract][Full Text] [Related]
16. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing. Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088 [TBL] [Abstract][Full Text] [Related]
17. High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures. Sirenko O; Hesley J; Rusyn I; Cromwell EF Assay Drug Dev Technol; 2014; 12(9-10):536-47. PubMed ID: 25506803 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes. Garside H; Marcoe KF; Chesnut-Speelman J; Foster AJ; Muthas D; Kenna JG; Warrior U; Bowes J; Baumgartner J Toxicol In Vitro; 2014 Mar; 28(2):171-81. PubMed ID: 24189122 [TBL] [Abstract][Full Text] [Related]
19. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells. Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575 [TBL] [Abstract][Full Text] [Related]
20. High-throughput toxicity testing of chemicals and mixtures in organotypic multi-cellular cultures of primary human hepatic cells. Orbach SM; Ehrich MF; Rajagopalan P Toxicol In Vitro; 2018 Sep; 51():83-94. PubMed ID: 29751030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]